Cystatin C and Uncontrolled Hypertension

Last updated: January 24, 2015
Sponsor: Ankara University
Overall Status: Completed

Phase

N/A

Condition

Stress

Williams Syndrome

Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT02334033
AnkaraUHyper
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Hypertension is an underdiagnosed and undertreated disease in real-life. Blood pressure and kidney functions are known to be closely related. Increased serum level of Cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. The investigators aimed to evaluate the predictive value of serum Cystatin C for control of hypertension in a community-based study.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Individuals who accept to participate to the survey

  • > 18 years

Exclusion

Exclusion Criteria:

  • Individuals who are not able to complete the questionnaire

  • Individuals who didn't give informed consent

Study Design

Total Participants: 903
Study Start date:
January 01, 2014
Estimated Completion Date:
January 31, 2015

Connect with a study center

  • Ankara University School Of Medicine, Department of Cardiology

    Ankara, 06230
    Turkey

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.